Mifepristone has been available to women in Europe for over a decade. It has been shown to be a safe and effective alternative to surgical abortion following extensive clinical trials in France, Great Britain, and Sweden. But this important reproductive health option has been heretofore unavailable to women in the U.S., largely due to anti-choice politics.
Mifepristone offers women an early, safe, and effective medical alternative to surgical abortion.
Under the current FDA-approved regimen it is administered by a woman's doctor and requires several visits to a clinic or doctor's office. The drug also holds promise for the treatment of other health conditions such as breast cancer, endometriosis, and Cushing's disease.